FluMist®

BIOLOGICAL7 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Stanford University

Conditions

Cystic FibrosisHealthyInfluenza

Phase 1

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

CompletedNCT03453801

Stanford UniversityHealthy, Influenza

Start: 2014-09-30End: 2019-01-14Updated: 2020-02-13

Phase 4

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

CompletedNCT03023553

Stanford UniversityInfluenza

Start: 2012-12-31End: 2013-02-28Updated: 2017-04-21

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

TerminatedNCT03023709

Stanford UniversityInfluenza

Start: 2015-09-30End: 2015-12-31Updated: 2017-05-10

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

CompletedNCT03023683

Stanford UniversityInfluenza

Start: 2012-10-31End: 2012-11-30Updated: 2021-10-18

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

TerminatedNCT03028987

Stanford UniversityInfluenza

Start: 2014-11-19End: 2015-11-18Updated: 2017-09-12

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

CompletedNCT03028974

Stanford UniversityInfluenza

Start: 2014-09-17End: 2017-11-20Updated: 2018-12-14

Unknown Phase

LAIV (Flumist®) Administration in CF Patients

McGill University Health Centre/Research Institute of the McGill University Health CentreCystic Fibrosis

Start: 2013-08-31End: 2015-12-31Target: 170Updated: 2014-09-16